217 related articles for article (PubMed ID: 36477458)
1. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus.
Hundscheid T; Onland W; Kooi EMW; Vijlbrief DC; de Vries WB; Dijkman KP; van Kaam AH; Villamor E; Kroon AA; Visser R; Mulder-de Tollenaer SM; De Bisschop B; Dijk PH; Avino D; Hocq C; Zecic A; Meeus M; de Baat T; Derriks F; Henriksen TB; Kyng KJ; Donders R; Nuytemans DHGM; Van Overmeire B; Mulder AL; de Boode WP;
N Engl J Med; 2023 Mar; 388(11):980-990. PubMed ID: 36477458
[TBL] [Abstract][Full Text] [Related]
2. Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan.
Hundscheid T; Donders R; Onland W; Kooi EMW; Vijlbrief DC; de Vries WB; Nuytemans DHGM; van Overmeire B; Mulder AL; de Boode WP;
Trials; 2021 Sep; 22(1):627. PubMed ID: 34526095
[TBL] [Abstract][Full Text] [Related]
3. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
Mitra S; Scrivens A; von Kursell AM; Disher T
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
[TBL] [Abstract][Full Text] [Related]
4. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
Hundscheid T; Onland W; van Overmeire B; Dijk P; van Kaam AHLC; Dijkman KP; Kooi EMW; Villamor E; Kroon AA; Visser R; Vijlbrief DC; de Tollenaer SM; Cools F; van Laere D; Johansson AB; Hocq C; Zecic A; Adang E; Donders R; de Vries W; van Heijst AFJ; de Boode WP
BMC Pediatr; 2018 Aug; 18(1):262. PubMed ID: 30077184
[TBL] [Abstract][Full Text] [Related]
5. Randomized Noninferiority Trial of Expectant Management versus Early Treatment of Patent Ductus Arteriosus in Preterm Infants.
Potsiurko S; Dobryanskyy D; Sekretar L; Salabay Z
Am J Perinatol; 2024 Apr; 41(6):730-738. PubMed ID: 35213904
[TBL] [Abstract][Full Text] [Related]
6. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD003481. PubMed ID: 30264852
[TBL] [Abstract][Full Text] [Related]
8. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2013 Apr; (4):CD003481. PubMed ID: 23633310
[TBL] [Abstract][Full Text] [Related]
9. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen.
Gupta S; Subhedar NV; Bell JL; Field D; Bowler U; Hutchison E; Johnson S; Kelsall W; Pepperell J; Roberts T; Sinha S; Stanbury K; Wyllie J; Hardy P; Juszczak E;
N Engl J Med; 2024 Jan; 390(4):314-325. PubMed ID: 38265644
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
[TBL] [Abstract][Full Text] [Related]
12. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
Jasani B; Mitra S; Shah PS
Cochrane Database Syst Rev; 2022 Dec; 12():CD010061. PubMed ID: 36519620
[TBL] [Abstract][Full Text] [Related]
13. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
[TBL] [Abstract][Full Text] [Related]
14. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
[TBL] [Abstract][Full Text] [Related]
15. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
Adamska E
Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
[TBL] [Abstract][Full Text] [Related]
17. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
18. Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial.
Gupta S; Juszczak E; Hardy P; Subhedar N; Wyllie J; Kelsall W; Sinha S; Johnson S; Roberts T; Hutchison E; Pepperell J; Linsell L; Bell JL; Stanbury K; Laube M; Edwards C; Field D;
BMC Pediatr; 2021 Feb; 21(1):100. PubMed ID: 33637074
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
